Pharmaron Beijing Co., Ltd. (SHE:300759)

China flag China · Delayed Price · Currency is CNY
30.92
+1.59 (5.42%)
Apr 28, 2026, 3:04 PM CST
33.33%
Market Cap 52.38B
Revenue (ttm) 14.10B
Net Income (ttm) 1.66B
Shares Out 1.83B
EPS (ttm) 0.94
PE Ratio 32.92
Forward PE 27.04
Dividend 0.20 (0.68%)
Ex-Dividend Date Jul 4, 2025
Volume 58,151,814
Average Volume 40,344,518
Open 29.40
Previous Close 29.33
Day's Range 29.40 - 31.45
52-Week Range 21.99 - 37.63
Beta 0.91
RSI 58.65
Earnings Date Mar 30, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Manufacturing Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleot... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 25,088
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300759
Full Company Profile

Financial Performance

In 2025, Pharmaron Beijing's revenue was 14.10 billion, an increase of 14.82% compared to the previous year's 12.28 billion. Earnings were 1.66 billion, a decrease of -7.22%.

Financial Statements

News

There is no news available yet.